- Home
- AUUD vs PRFX Comparison
AUUD vs PRFX Comparison
Compare AUUD & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- PRFX
- Stock Information
- Founded
- AUUD 2012
- PRFX 2007
- Country
- AUUD United States
- PRFX Israel
- Employees
- AUUD N/A
- PRFX N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- PRFX Health Care
- Exchange
- AUUD Nasdaq
- PRFX Nasdaq
- Market Cap
- AUUD 2.9M
- PRFX 3.0M
- IPO Year
- AUUD 2021
- PRFX 2020
- Fundamental
- Price
- AUUD $3.90
- PRFX $2.21
- Analyst Decision
- AUUD
- PRFX Hold
- Analyst Count
- AUUD 0
- PRFX 1
- Target Price
- AUUD N/A
- PRFX N/A
- AVG Volume (30 Days)
- AUUD 29.0K
- PRFX 45.5K
- Earning Date
- AUUD 03-05-2025
- PRFX 01-01-0001
- Dividend Yield
- AUUD N/A
- PRFX N/A
- EPS Growth
- AUUD N/A
- PRFX N/A
- EPS
- AUUD N/A
- PRFX N/A
- Revenue
- AUUD N/A
- PRFX N/A
- Revenue This Year
- AUUD N/A
- PRFX N/A
- Revenue Next Year
- AUUD N/A
- PRFX N/A
- P/E Ratio
- AUUD N/A
- PRFX N/A
- Revenue Growth
- AUUD N/A
- PRFX N/A
- 52 Week Low
- AUUD $3.35
- PRFX $0.43
- 52 Week High
- AUUD $96.90
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- AUUD 32.34
- PRFX 34.75
- Support Level
- AUUD $3.35
- PRFX $2.12
- Resistance Level
- AUUD $6.19
- PRFX $2.79
- Average True Range (ATR)
- AUUD 0.53
- PRFX 0.17
- MACD
- AUUD -0.08
- PRFX -0.05
- Stochastic Oscillator
- AUUD 6.69
- PRFX 17.77
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.